A case of basal cell carcinoma of the nose successfully treated with 5% imiquimod cream

Jun Ha Park, Eul Sang Hwang, Sang Baik Kim, Hyo Hyun Ahn, Il-Hwan Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Basal cell carcinoma is the most common malignant skin lesion. The major aim in the treatment of basal cell carcinoma is the curative treatment, which is best done by Mohs excision of the neoplastic tissue. Despite the effectiveness of surgical excision, non-surgical treatment modalities may be preferred for large tumor size or poor patient performance status. Imiquimod may offer an alternative to surgical excision. Imiquimod is an immune modulator acting as IFN-α and other cytokine inducer, stimulating the innate immune response. Imiquimod's anti-tumor effect may be mediated by IFN-α, IFN-γ, IL-12. At this time, there is no published experience on the treatment of basal cell carcinoma with imiquimod in Korea. We report a case of basal cell carcinoma of the nose successfully treated with topical 5% imiquimod cream.

Original languageEnglish
Pages (from-to)646-649
Number of pages4
JournalKorean Journal of Dermatology
Volume42
Issue number5
Publication statusPublished - 2004 May 1

Keywords

  • Basal cell carcinoma
  • Imiquimod

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'A case of basal cell carcinoma of the nose successfully treated with 5% imiquimod cream'. Together they form a unique fingerprint.

  • Cite this